Third-Party Testing

Third-party testing is analysis performed by a laboratory with no commercial stake in the result, as opposed to in-house testing by the manufacturer or seller. The independence claimed is of the laboratory from the party being checked. That is a real and useful separation, but it addresses only one of the several points at which a result can be made misleading, and in unregulated markets it is routinely presented as though it settled everything.

What a report contains matters more than who signed it. Chromatographic purity is an area percent within a defined method: it says what fraction of what the detector saw at one wavelength eluted as the main peak, and it neither identifies that peak nor measures how much substance is in the vial. Identity requires mass spectrometry, ideally with sequence-level fragmentation. Content requires a quantitative assay against a reference standard, which is what distinguishes net peptide content from gross powder weight. Sterility, endotoxin and water content are separate tests again, and a certificate omitting them is silent rather than reassuring.

Sampling is the other weak point. If the seller selects which lot to submit, packages it themselves and commissions the report, the laboratory has honestly analysed whatever it received. Blind purchase of retail units by an unrelated party is a materially stronger design, and the difference between the two is rarely visible on the document itself.

The failure to watch for is the report that never corresponds to the vial in hand. A certificate for one lot number tells you about that lot, and posting it against an entire catalogue is a substitution of evidence. Reports are also forged outright, so a document that cannot be confirmed directly with the issuing laboratory is an assertion, not a test result.